Latest Invent Ventures Inc. (IDEA) Headlines
Post# of 4
Posted On: 03/10/2014 5:22:36 AM
Latest Invent Ventures Inc. (IDEA) Headlines
CRWEWALLSTREETNEWSALEART Daily Stock Watch Invent Ventures, Inc. (OTCQB:IDEA), Crown Equity Holdings Inc. (OTCQB:CRWE), and HPC POS System Corp. (OTCQB:HPCS)
WorldStockWire - Mon Jul 29, 11:45AM CDT
CRWEWallstreetnewsalert.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our stock focus today is on:
INVENT Ventures Portfolio Company VIRURL Featured Again on Forbes.com
PR Newswire - Fri Jul 12, 7:00AM CDT
INVENT Ventures (OTC: IDEA) a business development company that invests in early-stage web technology companies, announced today its portfolio company VIRURL was written up in Forbes.com for the second time in the last seven months.
VIRURL Launches In Stream Ads for Bloggers
PR Newswire - Thu May 16, 10:20AM CDT
VIRURL, a Santa Monica start-up, launches In Stream Ads technology to publish relevant sponsored content directly into blogs.
Invent Ventures and Heliant Ventures co-invest in Sanguine BioSciences
M2 - Mon Mar 11, 10:10AM CDT
Invent Ventures, Inc. (OTC: IDEA) said it has led the seed financing round in Sanguine BioSciences, a biotechnology company empowering patients in biomedical research.
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
PR Newswire - Thu Mar 07, 8:09AM CST
INVENT Ventures, Inc. (OTC QB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has led the seed financing round in Sanguine BioSciences, a biotechnology company empowering patients in biomedical research. Along with INVENT, Heliant Ventures, a VC technology fund, jointly lead the round of investment in Sanguine.
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
PR Newswire - Thu Feb 21, 2:29PM CST
SANGUINE BIOSCIENCES, INC. ("Sanguine"), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures.
INVENT Ventures Engages Merriman Capital for Growth Financing Raise
PR Newswire - Thu Jan 03, 7:00AM CST
INVENT Ventures, Inc. (OTCQB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has signed an engagement agreement with Merriman Capital, Inc. and Financial Entrepreneur Platform member Core Equity Group LLC to raise growth financing for INVENT. The raise will be managed by venture banker Jon Buttles, Managing Partner of Core Equity Group LLC.
CRWEWALLSTREETNEWSALEART Daily Stock Watch Invent Ventures, Inc. (OTCQB:IDEA), Crown Equity Holdings Inc. (OTCQB:CRWE), and HPC POS System Corp. (OTCQB:HPCS)
WorldStockWire - Mon Jul 29, 11:45AM CDT
CRWEWallstreetnewsalert.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our stock focus today is on:
INVENT Ventures Portfolio Company VIRURL Featured Again on Forbes.com
PR Newswire - Fri Jul 12, 7:00AM CDT
INVENT Ventures (OTC: IDEA) a business development company that invests in early-stage web technology companies, announced today its portfolio company VIRURL was written up in Forbes.com for the second time in the last seven months.
VIRURL Launches In Stream Ads for Bloggers
PR Newswire - Thu May 16, 10:20AM CDT
VIRURL, a Santa Monica start-up, launches In Stream Ads technology to publish relevant sponsored content directly into blogs.
Invent Ventures and Heliant Ventures co-invest in Sanguine BioSciences
M2 - Mon Mar 11, 10:10AM CDT
Invent Ventures, Inc. (OTC: IDEA) said it has led the seed financing round in Sanguine BioSciences, a biotechnology company empowering patients in biomedical research.
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
PR Newswire - Thu Mar 07, 8:09AM CST
INVENT Ventures, Inc. (OTC QB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has led the seed financing round in Sanguine BioSciences, a biotechnology company empowering patients in biomedical research. Along with INVENT, Heliant Ventures, a VC technology fund, jointly lead the round of investment in Sanguine.
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
PR Newswire - Thu Feb 21, 2:29PM CST
SANGUINE BIOSCIENCES, INC. ("Sanguine"), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures.
INVENT Ventures Engages Merriman Capital for Growth Financing Raise
PR Newswire - Thu Jan 03, 7:00AM CST
INVENT Ventures, Inc. (OTCQB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has signed an engagement agreement with Merriman Capital, Inc. and Financial Entrepreneur Platform member Core Equity Group LLC to raise growth financing for INVENT. The raise will be managed by venture banker Jon Buttles, Managing Partner of Core Equity Group LLC.
(0)
(0)